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Abstract. – Background: Buschke-
Löwenstein tumour (BLT) or giant condyloma is
a verrucous infiltrating lesion, due to a sexually
transmitted virus infection, human papilloma
virus subtypes 6 and 11. Poor hygiene, promis-
cuity, chronic irritation and cellular immunocom-
promised states are often implicated in its gene-
sis. Typical treatment of giant condyloma in-
cludes imiquimod cream, podophillin resin,
cryotherapy, laser surgery, tangential shave exci-
sion with electrocautery.
Objective: The authors report their case load
in the treatment of giant condyloma and the re-
view of the modern therapies.
Methods and Materials: 27 consecutive pa-
tients (18 men, nine women) underwent surgery
for giant condylomata of perianal region and ex-
terna genitalia at the Department of Plastic
Surgery of the University of Palermo, from Octo-
ber 2006 to December 2009. All the patients had
been treated before with conservative therapies
without significant results. We performed the
radical excision with split-thickness skin graft in
all the patients.
Results: No significant complications have
occurred in all the cases. The functional and
aesthetic outcome were satisfying. No recur-
rence of disease were noticed in the follow-up.
Conclusion: the radical excision with split-
thickness skin graft appears to be a successful
option of treatment for Buschke-Löwenstein
tumours. Compared to other methods it does
not necessitate several stages of treatment,
moreover it has the advantage of a lower risk
of recurrence, it allows a complete histologic
examination, the healing process is rapid, the
improvement of quality of patients’s life is sig-
nificant.
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Introduction
Inizially described by Buschke and Löwen-
stein1, giant condyloma is a rare manifestation of
condyloma acuminatum, which may exceed 10 to
15 cm in diameter, due to a viral infection with
human papillomavirus types 6 and 11, transmit-
ted by sexual contact, autoinoculation, contact
with infected materials2.
Macroscopically it appears as a polypoid, cau-
liflower-like, exophytic mass, characterized by
slow growth, local infiltration, contiguous tissue
destruction, with high tendency to recurrence and
to produce fistulas or abscesses around the af-
fected area. Most frequent localization are the
surface of vulva, the scrotum, the penis, the per-
ineum and the perianal region (Figure 1), the in-
volvement of the rectum and bladder are ex-
tremely rare3. Is controversial the idea that
Buschke-Löwenstein tumour should be consid-
ered a premalignant lesion with an high potential
of malignant degeneration or a clinical manifes-
tation of verrucous carcinoma, some Authors re-
port its transformation into squamous carcinoma
after decades of growth4.
Modern Therapies
Different types of treatment are reported for
giant condyloma. However, because of its rarely,
literature consists mainly of case reports and
lacks controlled studies. The type of treatment
depends on many factors, including the size, the
location of the giant condyloma, the unsuccessful
previous therapies. Recurrences are frequent ex-
pecially after a conservative therapy.
The podofilox solution and gel are the first op-
tion of treatment for condyloma acuminata. With
the 0.5% solution, recurrences were found in one
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37% to 54% of the patients. Frequent adverse re-
actions are local itching, erithema, skin ulcera-
tion. Recurrence occurs in 19% of case after 12
weeks of follow-up13.
Cryotherapy by itself or in combination with
topical 5-fluorouracil was reported with good re-
sults in relatively small Buschke-Löwenstein tu-
mours14-15.
Laser: CO2 or argon laser are reserved for re-
lapsing cases or patients who have not received
the previously mentioned treatments as an alter-
native first-line treatment: its advantages are the
hemostatic incision and the wound sterilization16.
It is reported the systemic use of α-interferon
combined with neodymium: yttrium-aluminium
garnet laser therapy for local recurrence with sat-
isfactory results. However, no large series or
long-term results are yet available17.
Regional radiotherapy may induce undifferen-
tiation of the tumour cells, stimulating a rapid
progression of the lesion to the malignant degen-
eration18.
The surgical excision is still the first line of
treatment for Buschke-Löwenstein tumours, with
a highter success rate (63%-91%) and lower risk
of recurrence19. It allows the complete histopatho-
logic examination of the tumour, permitting to ex-
clude squamous cell carcinoma for which a radi-
cal aggressive surgery is mandatory. The Authors
shows that the wide excision of the lesion with
split-thickness skin graft can provide a good out-
come for patients with Buschke-Löwenstein tu-
mours, expecially for cases refractory to all forms
of medical therapy.
Patients and Methods
Twenty-seven consecutive patients (18 men,
nine women) underwent surgery for giant condy-
lomata of perianal region and external genitalia
at the Department of Plastic Surgery of Universi-
ty of Palermo, from October 2006 to December
2009. Mean age was 49 years (range 27-71). Tu-
mours’ secretion culture showed Escherichia coli
and negative-coagulase Staphylococci sp. Ten pa-
tients have been treated before with podofilox
gel, nine with crioteraphy, two with tangential
excision by electrocautery, but all them were re-
fractories to the treatments. After local or general
anesthesia, the radical excision with 20 mm of
margins was performed then, the split-thickness
skin graft. The donor site was for all the patients
third of the patients during the first month after the
treatment5. Podofilox gel, removes more than 64%
of the warts after 8 weeks of treatment6 with mod-
erate local adverse reaction. It is reported an high
risk of recurrence, probably because of the pres-
ence of virus in adjacent normal-appearing tissue7.
The antimetabolite 5-fluorouracil8,9, the
bleomycin combined with cisplatine or
methrotrexate10,11, the α-interferon12 in topical or
systemic administration, are possible option of
management to reduce the size of the giant
condyloma.
However, there are no guidelines or standard
doses, the treatments are expensive and require
multiple administrations. In addition, the adverse
events limit the therapy.
Imiquimod is an immune-response modifying
agent that induces the synthesis of interferon al-
fa, interleukine 1, 6 and 8 and other cytokines.
Topical 5% imiquimod cream applied 3 times per
week overnight for up to 16 weeks, would com-
pletely remove the condylomata acuminata in
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Figure 1. Clinical presentation of a Buschke-Löwenstein
tumour involving the pubis, the perineum, the left groin and
the anorectal region.
the medial region of the thigh: the skin graft was
thus processed through the skin mesher to ex-
pand its size (Figure 2 a-d).
The verrucous lesions localized inside the rec-
tum were excided with CO2 laser. Antibiotic pro-
phylaxis (2 g of intravenous cefazolin 30 minutes
before the operation) was administrated in all the
patients.
Results
The donor sites healed within 7-14 days in all
the cases. The attachment of the skin graft was
complete in 23 patients (Figure 2e). In four cas-
es, after the Pseudomonas aeruginosa infection,
a partial graft failure occurred, resulting in a pro-
longed healing process by second intention, with
frequent medications (three times a week) and
post-operative antibiotic administration for a
mean of seven days.
The lymphoedema was present in three pa-
tients at the genitalia, they were treated with
manual lymph drainage with a complete resolu-
tion after four weeks. In one patient the shortage
of the graft at the groin determined subacute pain
which required physical therapy for three months
and non-steroidal anti-inflammatory drugs
(NSAIDs) for two weeks, with complete resolu-
tion of the symptoms.
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Figure 2. A, Preoperative view. B, The giant condylomata are excided radically. C, Giant condylomata. D, Intraoperative
view after the split-thickness skin graft. E, Post-operative view after seven days.
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The hystopatologic analysis reported for all the
cases giant condylomata with intraepithelial hy-
perplasia without cellular atypia. It was not possi-
ble to determine which viral subtypes were in-
volved. All the patients were visited in the Insti-
tute during the follow-up (range 36-48 months).
No recurrences were noticed in all of them
(Figure 3a-c). All the patients compiled a form
about their satisfactory for functional and cos-
metic results. The 94% of the patients considered
excellent the final outcome.
Discussion
Buschke-Löwenstein tumour or giant condylo-
ma origins from condylomata acuminata, due to
the infection by the human papillomavirus. An es-
timated rate of 30% to 50% of sexually active
adults has genital human papillomavirus, and 2%
presents genital condylomata acuminata20. The gi-
ant condyloma differs from condylomata acumina-
ta because it can invade and destroy the adjacent
tissue. It is extremely rare, so experience with the
treatment of these tumours is difficult to accumu-
late. Its histological pattern is similar to the verru-
cous carcinoma, thus many Authors accept to in-
clude both the lesions under the term Buschke-
Löwenstein tumours18. It has been reported malig-
nant transformation in squamous cell carcinoma in
30-50% of patients21. The coexistence of Buschke-
Löwenstein tumour and squamous cell carcinoma
in the same site, changes the behaviour and
progress of the lesion19. For this reason we believe
that the only consistently effective therapy is wide
surgical excision of tumour with 20 mm margins,
followed by the split-thickness skin graft. This pro-
cedure is the best treatment of choise for giant
condilomata, permitting a complete histopatologic
examination, a more rapid healing and improved
final results, with a lower risk of recurrences. Al-
ternative treatment to surgery as laser surgery, pho-
todynamic therapy, cryotherapy, may also be ap-
plied in cases of rectal or vulvar localization, only
after a bioptic histologic analysis to exclude the
present of a squamous cell carcinoma.
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Figure 3. Post-operative view after. A, Two months. B, Six months. C, One year.
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